The published trial reported its findings, but the compound has not been approved for human use
If you haven't seen meaningful weight loss or lipid changes after three months of consistent semaglutide use, your doctor may increase your dose or explore additional factors like diet quality or medication timing
24th February 2025, A/Prof Chee L Khoo This is one of the most common questions asked at glucagon-like peptide 1 receptor agonist (GLP1-RA) CPD meetings
(ref) Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P